Science Times: Phase I/II Trial of Combination of Temozolomide Chemotherapy and Immunotherapy With Fusions of Dendritic and Glioma Cells in Patients With Glioblastoma

Standard treatment for newly diagnosed glioblastoma multiforme (GBM) includes surgical resection, followed by adjuvant radiation and concurrent temozolomide (TMZ) chemotherapy. Almost invariably, GBM acquires resistance to TMZ, resulting in tumor […]

Read Article →